Comparison of the inhibition effects of naringenin and its glycosides on LPS-induced inflammation in RAW 264.7 macrophages

Mol Biol Rep. 2024 Jan 2;51(1):56. doi: 10.1007/s11033-023-09147-0.

Abstract

Background: Inflammation is intricately linked to the development of various diseases, such as diabetes, cardiovascular diseases, and cancer. Flavonoids, commonly found in plants, are known for their diverse health benefits, including antioxidant and anti-inflammatory properties. These compounds are categorized into different classes based on their chemical structure. structures. However, limited research has compared the effects of flavonoid aglycones and flavonoid glycosides. This study aims to assess the anti-inflammatory effects of naringenin and its glycosides (naringin and narirutin) in RAW264.7 macrophages.

Methods and results: RAW264.7 cells were treated with naringenin, naringin, and narirutin, followed by stimulation with lipopolysaccharide. The levels of inflammatory mediators, including tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), nitric oxide (NO), inducible NO synthase (iNOS), and cyclooxygenase-2 (COX-2), were assessed. Additionally, the study examined nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) activation using western blot analysis. Among the compounds tested, narirutin exhibited the most potent anti-inflammatory effect against TNF-α, NO, and iNOS. Naringin and narirutin showed comparable inhibitory effects on IL-1β and COX-2. Both naringin and narirutin suppressed the expression of pro-inflammatory mediators by targeting different levels of the NF-κB and MAPK pathways. Naringenin demonstrated the weakest anti-inflammatory effect, primarily inhibiting NF-κB and reducing the phosphorylation levels of p38.

Conclusions: This study suggests that the presence of glycosides on naringenin and the varied binding forms of sugars in naringenin glycosides significantly influence the anti-inflammatory effects compared with naringenin in RAW 264.7 macrophages.

Keywords: Anti-inflammation; Mitogen-activated protein kinases (MAPK); Naringenin; Naringin; Narirutin; Nuclear factor-κB (NF-κB).

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Cyclooxygenase 2
  • Flavonoids
  • Glycosides* / pharmacology
  • Humans
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Inflammation Mediators
  • Lipopolysaccharides* / pharmacology
  • Macrophages
  • NF-kappa B
  • Tumor Necrosis Factor-alpha

Substances

  • naringenin
  • Glycosides
  • Lipopolysaccharides
  • Cyclooxygenase 2
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Flavonoids
  • Inflammation Mediators
  • Anti-Inflammatory Agents